{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:46:34Z","timestamp":1791999994230,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T00:00:00Z","timestamp":1481932800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00403-016-1709-9","type":"journal-article","created":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T11:18:33Z","timestamp":1481973513000},"page":"79-86","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients"],"prefix":"10.1007","volume":"309","author":[{"given":"Hanna","family":"My\u015bliwiec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Baran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Harasim-Symbor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Choroma\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"My\u015bliwiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Justyna","family":"Milewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Chabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Flisiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,17]]},"reference":[{"key":"1709_CR1","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/j.1468-3083.2007.02260.x","volume":"21","author":"M Akhyani","year":"2007","unstructured":"Akhyani M, Ehsani AH, Robati RM, Robati AM (2007) The lipid profile in psoriasis: a controlled study. J Eur Acad Dermatol Venereol 21:1330\u20131332","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1709_CR2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1523-1747.2001.01283.x","volume":"116","author":"F Alessandrini","year":"2001","unstructured":"Alessandrini F, Stachowitz S, Ring J, Behrendt H (2001) The level of prosaposin is decreased in the skin of patients with psoriasis vulgaris. J Invest Dermatol 116:394\u2013400","journal-title":"J Invest Dermatol"},{"key":"1709_CR3","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1007\/s00018-012-0917-5","volume":"69","author":"BT Bikman","year":"2012","unstructured":"Bikman BT (2012) A role for sphingolipids in the pathophysiology of obesity-induced inflammation. Cell Mol Life Sci 69:2135\u20132146","journal-title":"Cell Mol Life Sci"},{"key":"1709_CR4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.atherosclerosis.2007.09.018","volume":"196","author":"J Bismuth","year":"2008","unstructured":"Bismuth J, Lin P, Yao Q, Chen C (2008) Ceramide: a common pathway for atherosclerosis? Atherosclerosis 196:497\u2013504","journal-title":"Atherosclerosis"},{"key":"1709_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-016-0178-7","author":"S Borodzicz","year":"2016","unstructured":"Borodzicz S, Rudnicka L, Mirowska-Guzel D, Cudnoch-Jedrzejewska A (2016) The role of epidermal sphingolipids in dermatologic diseases. Lipids Health Dis. doi: 10.1186\/s12944-016-0178-7","journal-title":"Lipids Health Dis"},{"key":"1709_CR6","doi-asserted-by":"crossref","first-page":"21453","DOI":"10.1074\/jbc.C200176200","volume":"277","author":"V Brinkmann","year":"2002","unstructured":"Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, Hof R, Bruns C, Prieschl E, Baumruker T, Hiestand P, Foster CA, Zollinger M, Lynch KR (2002) The immune modulator FTY20 targets sphingosine 1-phosphate receptors. J Biol Chem 277:21453\u201321457","journal-title":"J Biol Chem"},{"key":"1709_CR7","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.tem.2015.07.006","volume":"26","author":"B Chaurasia","year":"2015","unstructured":"Chaurasia B, Summers SA (2015) Ceramides\u2014Lipotoxic inducers of metabolic disorders. Trends Endocrinol Metab 26:538\u2013550","journal-title":"Trends Endocrinol Metab"},{"key":"1709_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/srep12017","author":"A Checa","year":"2015","unstructured":"Checa A, Xu N, Sar DG, Haeggstrom JZ, Stahle M, Wheelock CE (2015) Circulating levels of sphingosine-1-phosphate are elevated in severe, but not mild psoriasis and are unresponsive to anti-TNF-\u03b1 treatment. Sci Rep. doi: 10.1038\/srep12017","journal-title":"Sci Rep"},{"key":"1709_CR9","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1080\/1744666X.2016.1201423","volume":"12","author":"A Chiricozzi","year":"2016","unstructured":"Chiricozzi A, Raimondo A, Lembo S, Fausti F, Dini V, Costanzo A, Monfrecola G, Balato N, Ayala F, Romanelli M, Balato A (2016) Crosstalk between skin inflammation and adipose tissue-derived products: pathogenic evidence linking psoriasis to increased adiposity. Expert Rev Clin Immunol 12:1299\u20131308","journal-title":"Expert Rev Clin Immunol"},{"key":"1709_CR10","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3346\/jkms.2004.19.6.859","volume":"19","author":"Y Cho","year":"2004","unstructured":"Cho Y, Lew BL, Seong K, Kim NI (2004) An inverse relationship between ceramide synthesis and clinical severity in patients with psoriasis. J Korean Med Sci 19:859\u2013863","journal-title":"J Korean Med Sci"},{"key":"1709_CR11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0002-8703(03)00118-2","volume":"146","author":"DH Deutschman","year":"2003","unstructured":"Deutschman DH, Carstens JS, Klepper RL, Smith WS, Page MT, Young TR, Gleason LA, Nakajima N, Sabbadini RA (2003) Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate. Am Heart J 146:62\u201368","journal-title":"Am Heart J"},{"key":"1709_CR12","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/jdv.12742","volume":"29","author":"E Edson-Heredia","year":"2015","unstructured":"Edson-Heredia E, Zhu B, Lefevre C, Wang M, Barrett A, Bushe CJ, Cox A, Wu JJ, Maeda-Chubachi T (2015) Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink. J Eur Acad Dermatol Venereol 29:955\u2013963","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1709_CR13","first-page":"1043","volume":"60","author":"MA Asmi El","year":"2014","unstructured":"El Asmi MA, Zidi W, Mebazaa A, Zayani Y, Ayadi I, Feki M, Ben Osman A, Kaabachi N (2014) Serum lipid level in Tunisian patients with psoriasis. Clin Lab 60:1043\u20131047","journal-title":"Clin Lab"},{"key":"1709_CR14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2133.2007.07986.x","volume":"157","author":"P Gisondi","year":"2007","unstructured":"Gisondi P, Tesari G, Ci-onti A, Piaserico S, Schianchi S, Peserico A, Giannetti A, Girolomoni G (2007) Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 157:68\u201373","journal-title":"Br J Dermatol"},{"issue":"suppl","key":"1709_CR15","doi-asserted-by":"publisher","first-page":"ii14","DOI":"10.1136\/ard.2004.032482","volume":"64","author":"DD Gladman","year":"2005","unstructured":"Gladman DD, Antoni C, Mease P, Clegg DO, Nash P (2005) Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 64(suppl):ii14\u201317. doi: 10.1136\/ard.2004.032482","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"1709_CR16","doi-asserted-by":"crossref","first-page":"e0138130","DOI":"10.1371\/journal.pone.0138130","volume":"10","author":"G Grammatikos","year":"2015","unstructured":"Grammatikos G, Ferreir\u00f2s N, Waidmann O, Bon D, Schroeter S, Koch A, Herrmann E, Zeuzem S, Kronenberger B, Pfeilschifter J (2015) Serum sphingolipid variations associate with hepatic decompensation and survival in patients with cirrhosis. PLoS One 10(9):e0138130","journal-title":"PLoS One"},{"key":"1709_CR17","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.bbalip.2014.04.007","volume":"1841","author":"G Grammatikos","year":"2014","unstructured":"Grammatikos G, Muhle C, Ferreiros N, Schroeter S, Bogdanou D, Schwalm S, Hintereder G, Kornhuber J, Zeuzem S, Sarrazin C, Pfeilschifter J (2014) Serum acid sphingomyelinase is upregulated in chronic hepatitis C infection and non alcoholic fatty liver disease. Biochim Biophys Acta 1841:1012\u20131020","journal-title":"Biochim Biophys Acta"},{"key":"1709_CR18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00128071-200708060-00002","volume":"8","author":"T Herzinger","year":"2007","unstructured":"Herzinger T, Kleuser B, Schafer-Korting M, Korting HC (2007) Sphingosine-1-phosphate signaling and the skin. Am J Clin Dermatol 8:329\u2013336","journal-title":"Am J Clin Dermatol"},{"key":"1709_CR19","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.metabol.2014.07.001","volume":"63","author":"RL Klein","year":"2014","unstructured":"Klein RL, Hammad SM, Baker NL, Hunt KJ, Al Gadban MM, Cleary PA, Virella G, Lopes-Virella MF, DCCT\/EDIC Research Group (2014) Decreased plasma levels of select very long chain ceramide species are associated with the development of nephropathy in type 1 diabetes. Metabolism 63:1287\u20131295","journal-title":"Metabolism"},{"issue":"3","key":"1709_CR20","doi-asserted-by":"crossref","first-page":"e91769","DOI":"10.1371\/journal.pone.0091769","volume":"9","author":"MK Kosinska","year":"2014","unstructured":"Kosinska MK, Liebisch G, Lochnit G, Wilhelm J, Klein H, Kaesser U, Lasczkowski G, Rickert M, Schmitz G, Steinmeyer J (2014) Sphingolipids in human synovial fluid\u2014a lipidomic study. PLoS One 9(3):e91769","journal-title":"PLoS One"},{"key":"1709_CR21","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1194\/jlr.R059543","volume":"56","author":"M Ksi\u0105\u017cek","year":"2015","unstructured":"Ksi\u0105\u017cek M, Chaci\u0144ska M, Chabowski A, Baranowski M (2015) Sources, metabolism, and regulation of circulating sphingosine-1-phosphate. J Lipid Res 56:1271\u20131281","journal-title":"J Lipid Res"},{"issue":"9","key":"1709_CR22","doi-asserted-by":"crossref","first-page":"e72449","DOI":"10.1371\/journal.pone.0072449","volume":"8","author":"GM Kowalski","year":"2013","unstructured":"Kowalski GM, Carey AL, Selathurai A, Kingwell BA, Bruce CR (2013) Plasma sphingosine-1-phosphate is elevated in obesity. PLoS One 8(9):e72449","journal-title":"PLoS One"},{"key":"1709_CR23","first-page":"727","volume":"4","author":"WQ Lai","year":"2012","unstructured":"Lai WQ, Chia FL, Leung BP (2012) Sphingosine kinase and sphingosine-1-phosphate receptors: novel therapeutic targets of rheumatoid arthritis Future. Med Chem 4:727\u2013733","journal-title":"Med Chem"},{"key":"1709_CR24","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000018394","volume":"200","author":"M Laporte","year":"2000","unstructured":"Laporte M, Galand P, Fokan D, de Graef C, Heenen M (2000) Apoptosis in established and healing psoriasis. Dermatology 200:314\u2013316","journal-title":"Dermatology"},{"key":"1709_CR25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3346\/jkms.2006.21.1.95","volume":"21","author":"BL Lew","year":"2006","unstructured":"Lew BL, Cho Y, Kim J, Sim WY, Kim NI (2006) Ceramides and cell signaling molecules in psoriatic epidermis: reduced levels of ceramides, PKC-\u03b1, and JNK. J Korean Med Sci 21:95\u201399","journal-title":"J Korean Med Sci"},{"key":"1709_CR26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000315104","volume":"26","author":"X Li","year":"2010","unstructured":"Li X, Becker KA, Zhang Y (2010) Ceramide in redox signaling and cardiovascular diseases. Cell Physiol Biochem 26:41\u201348","journal-title":"Cell Physiol Biochem"},{"key":"1709_CR27","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.2741\/4458","volume":"21","author":"N Li","year":"2016","unstructured":"Li N, Zhang F (2016) Implication of sphingosine-1-phosphate in cardiovascular regulation. Front Biosci (Landmark Ed) 21:1296\u20131313","journal-title":"Front Biosci (Landmark Ed)"},{"key":"1709_CR28","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1515\/jpem-2012-0407","volume":"26","author":"X Lopez","year":"2013","unstructured":"Lopez X, Goldfine AB, Holland WL, Gordillo R, Scherer PE (2013) Plasma Ceramides are elevated in female children and adolescents with type 2 diabetes. J Pediatr Endocrinol Metab 26:995\u2013998","journal-title":"J Pediatr Endocrinol Metab"},{"key":"1709_CR29","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","volume":"445","author":"MA Lowes","year":"2007","unstructured":"Lowes MA, Bowcock AM, Krueger JG (2007) Pathogenesis and therapy of psoriasis. Nature 445:866\u2013873","journal-title":"Nature"},{"key":"1709_CR30","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s12020-011-9589-4","volume":"41","author":"I Majumdar","year":"2012","unstructured":"Majumdar I, Mastrandrea LD (2012) Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome. Endocrine 41:442\u2013449","journal-title":"Endocrine"},{"key":"1709_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5455\/medarh.2015.69.85-87","volume":"69","author":"E Malkic Salihbegovic","year":"2015","unstructured":"Malkic Salihbegovic E, Hadzigrahic N, Cickusic AJ (2015) Psoriasis and metabolic syndrome. Med Arch 69:85\u201387. doi: 10.5455\/medarh.2015.69.85-87","journal-title":"Med Arch"},{"key":"1709_CR32","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cellsig.2006.09.004","volume":"19","author":"D Mechtcheriakova","year":"2007","unstructured":"Mechtcheriakova D, Wlachos A, Sobanov J, Kopp T, Reuschel R, Bornancin F, Cai R, Zemann B, Urtz N, Stingl G, Zlabinger G, Woisetschlager M, Baumruker T, Bilich A (2007) Sphingosine 1-phosphate phosphatase 2 is induced during inflammatory responses. Cell Signal 19:748\u2013760","journal-title":"Cell Signal"},{"key":"1709_CR33","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/bbrc.2000.2239","volume":"269","author":"K Migita","year":"2000","unstructured":"Migita K, Honda S, Yamasaki S, Hirai Y, Fukuda T, Aoyagi T, Kita M, Ida H, Tsukada T, Kawakami A, Kawabe Y, Eguchi K (2000) Regulation of rheumatoid synovial cell growth by ceramide. Biochem Biophys Res Commun 269:70\u201375","journal-title":"Biochem Biophys Res Commun"},{"key":"1709_CR34","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/ard.57.8.495","volume":"57","author":"N Mizushima","year":"1998","unstructured":"Mizushima N, Kohsaka H, Miyasaka N (1998) Ceramide, a mediator of interleukin 1, tumor necrosis factor alpha, as well as Fas receptor signaling, induces apoptosis of rheumatoid arthritis synovial cells. Ann Rheum Dis 57:495\u2013499","journal-title":"Ann Rheum Dis"},{"key":"1709_CR35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.5021\/ad.2013.25.3.321","volume":"25","author":"SH Moon","year":"2013","unstructured":"Moon SH, Kim JY, Song EH, Shin MK, Cho YH, Kim NI (2013) Altered levels of sphingosine and sphinganine on psoriatic epidermis. Ann Dermatol 25:321\u2013326","journal-title":"Ann Dermatol"},{"key":"1709_CR36","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1172\/JCI76369","volume":"125","author":"RL Proia","year":"2015","unstructured":"Proia RL, Hla T (2015) Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy. J Clin Invest 125:1379\u20131387","journal-title":"J Clin Invest"},{"key":"1709_CR37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1468-3083.2001.00192.x","volume":"15","author":"SP Raychaudhuri","year":"2001","unstructured":"Raychaudhuri SP, Farber EM (2001) The prevalence of psoriasis in the world. J Eur Acad Dermatol Venereol 15:16\u201317","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1709_CR38","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.2337\/db06-0330","volume":"55","author":"F Samad","year":"2006","unstructured":"Samad F, Hester KD, Yang G, Hannun YA, Bielawski J (2006) Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes 55:2579\u20132587","journal-title":"Diabetes"},{"key":"1709_CR39","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000083509","volume":"210","author":"J Schmitt","year":"2005","unstructured":"Schmitt J, Wozel G (2005) The Psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology 210:194\u2013199","journal-title":"Dermatology"},{"key":"1709_CR40","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/jid.2013.364","volume":"134","author":"C Tawada","year":"2014","unstructured":"Tawada C, Kanoh H, Nakamura M, Mizutani Y, Fujisawa T, Banno Y, Seishima M (2014) Interferon-\u03b3 decreases ceramides with long-chain fatty acids: possible involvement in atopic dermatitis and psoriasis. J Invest Dermatol 134:712\u2013718","journal-title":"J Invest Dermatol"},{"key":"1709_CR41","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s40265-016-0603-2","volume":"76","author":"HC Tsai","year":"2016","unstructured":"Tsai HC, Han MH (2016) Sphingosine-1-phosphate (S1P) and S1P signaling pathway: therapeutic targets in autoimmunity and inflammation. Drugs 76:1067\u20131079","journal-title":"Drugs"},{"key":"1709_CR42","first-page":"1321","volume":"151","author":"T Wrone-Smith","year":"1997","unstructured":"Wrone-Smith T, Mitra RS, Thompson CB, Jasty R, Castle VP, Nickoloff BJ (1997) Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin. Am J Pathol 151:1321\u20131329","journal-title":"Am J Pathol"},{"key":"1709_CR43","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cjca.2014.12.007","volume":"31","author":"J Yu","year":"2015","unstructured":"Yu J, Pan W, Shi R, Yang T, Li Y, Bai Y, Schuchman EH, He X, Zhang G (2015) Ceramide is upregulated and associated with mortality in patients with chronic heart failure. Can J Cardiol 31:357\u2013363","journal-title":"Can J Cardiol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-016-1709-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-016-1709-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-016-1709-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T02:08:22Z","timestamp":1498356502000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-016-1709-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,17]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["1709"],"URL":"https:\/\/doi.org\/10.1007\/s00403-016-1709-9","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,17]]}}}